FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 389
and the quality of life but may nevertheless have a great impact on safety. Conversely, many
emotional problems that are of therapeutic and clinical concern have no impact on safety.
B. Denials. The FAA has concluded that certain psychiatric conditions are such that their presence
or a past history of their presence is sufficient to suggest a significant potential threat to aviation
safety. It is, therefore, incumbent upon the AME to be aware of any indications of these conditions
currently or in the past, and to deny or defer issuance of the medical certificate to an applicant who
has a history of these conditions. An applicant who has a current diagnosis or history of these
conditions may request the FAA to grant an Authorization under the special issuance section of
part 67 (14 CFR 67.401) and, based upon individual considerations, the FAA may grant such an
issuance.
All applicants with any of the following conditions must be denied or deferred:
Attention deficit/hyperactivity, bipolar disorder, personality disorder, psychosis, substance
abuse, substance dependence, suicide attempt.
In some instances, the following conditions may also warrant denial or deferral:
Adjustment disorder; bereavement; dysthymic; or minor depression; use of psychotropic
medications for smoking cessation
NOTE: The use of a psychotropic drug is disqualifying for aeromedical certification purposes. This
includes all sedatives, tranquilizers, antipsychotic drugs, antidepressant drugs (including SSRI’s - see
exceptions below), analeptics, anxiolytics, and hallucinogens. The AME should defer issuance and
forward the medical records to the AMCD.
C. Use of Antidepressant Medications. (Updated 05/31/2023) The FAA has determined that
applicants requesting first, second, or third-class medical certificates while being treated with
one of several specific antidepressant medications may be considered. The Authorization
decision is made on a case-by-case basis. The AME may not issue.
If the applicant opts to discontinue use of the SSRI, the AME must notate in Block 60, Comments
on History and Findings, on FAA Form 8500-8 and defer issuance. To reapply for regular
issuance, the applicant must be off the SSRI for a minimum of 60 days with a favorable report
from the treating physician indicating stable mood and no aeromedically significant side effects.
See SSRI Decision Path I
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
Related guidance
Navigation aids drawn from the Guide's own structure and explicit cross-references. They are not medical or certification decisions.
FAA Guide for Aviation Medical Examiners, Version 10/28/2026, page 389. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source.
“…from the FAA III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 47., Psychiatric, Aerospace Medical Disposition table. IV. PROTOCOL: See Substances of Dependence/Abuse V. PHARMACE…”